Terumo Corporation (4543.T)
Makes medical devices for heart surgery, stroke treatment, injections, and blood processing worldwide.
2,382.50+0.04%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago-7.1%
The outlook
Terumo trades near the middle of its 52-week range and above both its 50- and 200-day moving averages, showing a stable uptrend. Analyst consensus leans bullish with the average price target sitting roughly 24% above the current level. The stock carries a trailing P/E of 25.9, reflecting a premium valuation relative to its earnings.
What’s behind the score
Analyst consensusBuy — 1.6 avg of 13 analysts
Price trendAbove its 50- & 200-day averages
52-week range53% of the way from its 52-week low to high
Price targetAvg target +24% vs current price
Analyst price target
~12-month · 13 analysts2,961.54average target+24.3% vs now
Now 2,382.50
Low 2,100.00High 3,700.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$3.51T
52-wk high
2,818.00
52-wk low
1,900.00
50-day avg
2,260.65
200-day avg
2,224.21
Trailing P/E
25.9